spacer
Eyepea Management Services - Intellectual Property ServicesIntellectual Property Management Service. A Registered Trademark Agent » Bookmark this page
IP Services
Home
Trademark Search
Trademark Registration
Trademark Renewal
Trademark Assignment
Request for Service
IP Resources
Intellectual Property
Trademark
Copyright
Patent
Book Store
Latest IP News
TM Common Terms
Nice Classification
About Eyepea
Contact Us
About Us
 
IP & Trademark Related Book List
Keyword    (e.g. how to patent)

An Emerging Biotech Giant? : An article from: The China Business Review


An Emerging Biotech Giant? : An article from: The China Business Review An Emerging Biotech Giant? : An article from: The China Business Review

Offer Price: USD $10.00

See Latest Price & Discount

Author Matthew Chervenak
Binding: Digital
Publication Date: 2005-06-30
Publisher:U.S.-China Business Council


Editorial Reviews:

Book Description
Challenging global players, Chinese companies have begun to compete in lower-end bio-equipment, reagents, and consumables. China's biotech industry has emerged largely because of beneficial policy changes, increased program funding, low labor costs, and reorganization of China's science and technology system. Bio-related technologies have applications in a wide variety of industries. These industries are: 1. biopharmaceuticals, 2. new drug development, 3. lab supplies, 4. bio-services, 5. chemical and enzymes, 6. agri-and aquaculture, and 7. environmental products and services. Intellectual property and an underdeveloped capital market remain the largest barriers to biotech growth in China. A lack of management and investor seasoning is also a hindrance to foreign participation in China's biotech industry. Despite the sector's weaknesses, China's strengths -- low-cost, highly skilled technologists and scientists, a strong track record in life-science research, a high-quality returnee pool, advantageous policies and tax treatment, and China's entrepreneurial culture -- all indicate a promising future.

This digital document is an article from The China Business Review, most recently published by U.S.-China Business Council on June 30, 2005. The length of the article is 2748 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: An Emerging Biotech Giant?
Author: Matthew Chervenak
Publication:The China Business Review (Feature)
Date: June 30, 2005
Publisher: U.S.-China Business Council
Volume: 32 Issue: 3 Page: 48-51,60

Distributed by ProQuest Information and Learning
spacer

Eyepea Management Services is now part of Intellect Front. Based in Malaysia, Singapore, and U.S., Intellect Front specializes in trademark & intellectual property portfolio management.
© 2008 Intellect Front. All Rights Reserved. Privacy Policy
Powered by Genuine Technology
spacer